(Q37689780)

22 August 2017

title

Corticotropin-releasing factor receptor antagonists (English)

1 reference

22 August 2017

Paul J Gilligan

1

1 reference

22 August 2017

language of work or name

English

0 references

publication date

1 July 2006

1 reference

Expert Opinion on Therapeutic Patents

22 August 2017

published in

1 reference

22 August 2017

volume

16

1 reference

22 August 2017

issue

7

1 reference

22 August 2017

page(s)

913-924

1 reference

Treatment of mood disorders

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543776.16.7.913

Research and treatment approaches to depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.16.7.913

Corticotropin releasing factor (CRF) receptor modulators: progress and opportunities for new therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.16.7.913

CRF and CRF receptors: role in stress responsivity and other behaviors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.16.7.913

The CRF peptide family and their receptors: yet more partners discovered

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.16.7.913

Structural requirements for peptidic antagonists of the corticotropin-releasing factor receptor (CRFR): development of CRFR2beta-selective antisauvagine-30

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.16.7.913

Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.16.7.913

A single amino acid serves as an affinity switch between the receptor and the binding protein of corticotropin-releasing factor: implications for the design of agonists and antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.16.7.913

The role of CRF receptors in anxiety and depression: implications of the novel CRF1 agonist cortagine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.16.7.913

Non-peptide corticotropin-releasing hormone antagonists: syntheses and structure-activity relationships of 2-anilinopyrimidines and -triazines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.16.7.913

CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.16.7.913

Synthesis and oral efficacy of a 4-(butylethylamino)pyrrolo[2,3-d]pyrimidine: a centrally active corticotropin-releasing factor1 receptor antagonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.16.7.913

Design, synthesis, and biological evaluation of 1,2,3,7-tetrahydro-6h-purin-6-one and 3,7-dihydro-1h-purine-2,6-dione derivatives as corticotropin-releasing factor(1) receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.16.7.913

Synthesis, structure-activity relationships, and in vivo properties of 3,4-dihydro-1H-pyrido[2,3-b]pyrazin-2-ones as corticotropin-releasing factor-1 receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.16.7.913

Synthesis, structure-activity relationships, and anxiolytic activity of 7-aryl-6,7-dihydroimidazoimidazole corticotropin-releasing factor 1 receptor antagonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.16.7.913

Potent, orally active corticotropin-releasing factor receptor-1 antagonists containing a tricyclic pyrrolopyridine or pyrazolopyridine core

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.16.7.913

Design and synthesis of tricyclic imidazo[4,5-b]pyridin-2-ones as corticotropin-releasing factor-1 antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.16.7.913

Rational design, synthesis, and structure-activity relationships of aryltriazoles as novel corticotropin-releasing factor-1 receptor antagonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.16.7.913

Increased hepatobiliary clearance of unconjugated thyroxine determines DMP 904-induced alterations in thyroid hormone homeostasis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.16.7.913

10.1517/13543776.16.7.913

21 January 2018

Identifiers

DOI

1 reference

22 August 2017

1 reference